JP2025506667A5 - - Google Patents
Info
- Publication number
- JP2025506667A5 JP2025506667A5 JP2024547925A JP2024547925A JP2025506667A5 JP 2025506667 A5 JP2025506667 A5 JP 2025506667A5 JP 2024547925 A JP2024547925 A JP 2024547925A JP 2024547925 A JP2024547925 A JP 2024547925A JP 2025506667 A5 JP2025506667 A5 JP 2025506667A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- represented
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263309923P | 2022-02-14 | 2022-02-14 | |
| US63/309,923 | 2022-02-14 | ||
| PCT/US2023/012879 WO2023154499A1 (en) | 2022-02-14 | 2023-02-13 | Emopamil-binding protein inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506667A JP2025506667A (ja) | 2025-03-13 |
| JP2025506667A5 true JP2025506667A5 (cg-RX-API-DMAC10.html) | 2026-02-24 |
Family
ID=85505736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547925A Pending JP2025506667A (ja) | 2022-02-14 | 2023-02-13 | エモパミル結合タンパク質阻害剤及びその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250152574A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4479384A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025506667A (cg-RX-API-DMAC10.html) |
| CN (1) | CN119731156A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023154499A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY40865A (es) * | 2023-08-23 | 2025-02-14 | Biogen Ma Inc | Inhibidores de la proteína de unión al emopamilo y usos de estos |
| EP4766448A1 (en) * | 2023-08-25 | 2026-07-01 | Biogen MA Inc. | EMOPAMIL-BINDING PROTEIN INHIBITORS AND THEIR USES |
| WO2025049419A1 (en) * | 2023-08-28 | 2025-03-06 | Genzyme Corporation | Pyrazolyl compounds as emopamil binding protein inhibitors |
| WO2026112292A1 (en) * | 2024-11-20 | 2026-05-28 | Convelo Therapeutics, Inc. | Spirocyclic compounds for use in promoting remyelination |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10082496B2 (en) * | 2014-09-10 | 2018-09-25 | Board Of Regents Of The University Of Texas System | Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis |
| MA44037B1 (fr) * | 2016-06-06 | 2020-03-31 | Arena Pharm Inc | Modulateurs du récepteur adrénergique bêta 3 utile dans le traitement ou la prévention de troubles associés à ceux-ci |
-
2023
- 2023-02-13 JP JP2024547925A patent/JP2025506667A/ja active Pending
- 2023-02-13 CN CN202380033932.3A patent/CN119731156A/zh active Pending
- 2023-02-13 WO PCT/US2023/012879 patent/WO2023154499A1/en not_active Ceased
- 2023-02-13 EP EP23709534.4A patent/EP4479384A1/en active Pending
- 2023-02-13 US US18/837,245 patent/US20250152574A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2454405C2 (ru) | Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина | |
| HRP20241159T1 (hr) | Heterociklički agonisti za glp-1 | |
| JP2022553376A5 (cg-RX-API-DMAC10.html) | ||
| JP2010525023A5 (cg-RX-API-DMAC10.html) | ||
| JP2014506917A (ja) | 新規キナーゼ阻害剤 | |
| CA2672373A1 (en) | Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases | |
| JP2022552324A5 (cg-RX-API-DMAC10.html) | ||
| JP2023521351A5 (cg-RX-API-DMAC10.html) | ||
| JP2010538076A5 (cg-RX-API-DMAC10.html) | ||
| JP2022553832A5 (cg-RX-API-DMAC10.html) | ||
| JP2010006817A (ja) | 炎症性障害を治療する化合物 | |
| RU2015143718A (ru) | N-ацил-N'-(пиридин-2-ил) карбамиды и их аналоги, проявляющие противораковую и антипролиферативную активность | |
| JP2019536785A5 (cg-RX-API-DMAC10.html) | ||
| JP2011502956A5 (cg-RX-API-DMAC10.html) | ||
| JP2011126891A (ja) | ２−アシルアミノ−４−フェニルチアゾール誘導体の合成中間体 | |
| JP2015514794A5 (cg-RX-API-DMAC10.html) | ||
| RU2018131766A (ru) | 6-гетероциклил-4-морфолин-4-илпиридин-2-оны, пригодные для лечения рака и диабета | |
| JP2024525797A5 (cg-RX-API-DMAC10.html) | ||
| JP2004532227A5 (cg-RX-API-DMAC10.html) | ||
| RU2019136279A (ru) | C5 -Анилинохиназолиновые соединения и их использование в лечении рака | |
| RU2005136368A (ru) | Производные пиперазина и их применение для лечения неврологических и психиатрических заболеваний | |
| JP2019530745A5 (cg-RX-API-DMAC10.html) | ||
| JP6413032B2 (ja) | 新規ｄｇａｔ２阻害剤 | |
| JP2016532669A5 (cg-RX-API-DMAC10.html) | ||
| JP2020521766A5 (cg-RX-API-DMAC10.html) |